nodes	percent_of_prediction	percent_of_DWPC	metapath
Vitamin E—NQO1—urinary bladder cancer	0.22	0.575	CbGaD
Vitamin E—GSTP1—urinary bladder cancer	0.163	0.425	CbGaD
Vitamin E—SOD1—Carboplatin—urinary bladder cancer	0.0902	0.215	CbGbCtD
Vitamin E—SOD1—Cisplatin—urinary bladder cancer	0.0771	0.184	CbGbCtD
Vitamin E—NQO1—Carboplatin—urinary bladder cancer	0.0518	0.123	CbGbCtD
Vitamin E—GSTP1—Carboplatin—urinary bladder cancer	0.0472	0.112	CbGbCtD
Vitamin E—NQO1—Cisplatin—urinary bladder cancer	0.0443	0.105	CbGbCtD
Vitamin E—GSTP1—Cisplatin—urinary bladder cancer	0.0403	0.0959	CbGbCtD
Vitamin E—GSTP1—Etoposide—urinary bladder cancer	0.0396	0.0943	CbGbCtD
Vitamin E—NQO1—Doxorubicin—urinary bladder cancer	0.0297	0.0706	CbGbCtD
Vitamin E—HMOX1—penis—urinary bladder cancer	0.00538	0.0759	CbGeAlD
Vitamin E—GSTA2—urine—urinary bladder cancer	0.0022	0.031	CbGeAlD
Vitamin E—SEC14L2—prostate gland—urinary bladder cancer	0.00214	0.0301	CbGeAlD
Vitamin E—PRKCB—prostate gland—urinary bladder cancer	0.00214	0.0301	CbGeAlD
Vitamin E—TTPA—renal system—urinary bladder cancer	0.00212	0.0299	CbGeAlD
Vitamin E—DGKA—prostate gland—urinary bladder cancer	0.00176	0.0249	CbGeAlD
Vitamin E—PPP2CA—prostate gland—urinary bladder cancer	0.00174	0.0245	CbGeAlD
Vitamin E—PPP2CB—prostate gland—urinary bladder cancer	0.00148	0.0209	CbGeAlD
Vitamin E—SEC14L2—renal system—urinary bladder cancer	0.00146	0.0205	CbGeAlD
Vitamin E—GSTP1—urine—urinary bladder cancer	0.00141	0.0199	CbGeAlD
Vitamin E—HMOX1—prostate gland—urinary bladder cancer	0.00129	0.0181	CbGeAlD
Vitamin E—PPP2CA—epithelium—urinary bladder cancer	0.00128	0.018	CbGeAlD
Vitamin E—PPP2CA—renal system—urinary bladder cancer	0.00119	0.0167	CbGeAlD
Vitamin E—SEC14L2—female reproductive system—urinary bladder cancer	0.00117	0.0164	CbGeAlD
Vitamin E—GCLC—prostate gland—urinary bladder cancer	0.00111	0.0157	CbGeAlD
Vitamin E—HMOX1—seminal vesicle—urinary bladder cancer	0.00109	0.0153	CbGeAlD
Vitamin E—PPP2CB—renal system—urinary bladder cancer	0.00101	0.0142	CbGeAlD
Vitamin E—GSTM3—prostate gland—urinary bladder cancer	0.000993	0.014	CbGeAlD
Vitamin E—DGKA—female reproductive system—urinary bladder cancer	0.000963	0.0136	CbGeAlD
Vitamin E—PPP2CA—female reproductive system—urinary bladder cancer	0.00095	0.0134	CbGeAlD
Vitamin E—HMOX1—epithelium—urinary bladder cancer	0.000945	0.0133	CbGeAlD
Vitamin E—GSTO1—prostate gland—urinary bladder cancer	0.000924	0.013	CbGeAlD
Vitamin E—HMOX1—smooth muscle tissue—urinary bladder cancer	0.00091	0.0128	CbGeAlD
Vitamin E—HMOX1—renal system—urinary bladder cancer	0.000876	0.0124	CbGeAlD
Vitamin E—SOD1—prostate gland—urinary bladder cancer	0.00085	0.012	CbGeAlD
Vitamin E—GSTM3—seminal vesicle—urinary bladder cancer	0.00084	0.0118	CbGeAlD
Vitamin E—PRKCA—prostate gland—urinary bladder cancer	0.000823	0.0116	CbGeAlD
Vitamin E—GCLC—epithelium—urinary bladder cancer	0.000817	0.0115	CbGeAlD
Vitamin E—PPP2CB—female reproductive system—urinary bladder cancer	0.000808	0.0114	CbGeAlD
Vitamin E—GSTA2—prostate gland—urinary bladder cancer	0.000789	0.0111	CbGeAlD
Vitamin E—GSTO1—seminal vesicle—urinary bladder cancer	0.000782	0.011	CbGeAlD
Vitamin E—GCLC—renal system—urinary bladder cancer	0.000758	0.0107	CbGeAlD
Vitamin E—PPP2CB—vagina—urinary bladder cancer	0.000731	0.0103	CbGeAlD
Vitamin E—SOD1—seminal vesicle—urinary bladder cancer	0.000719	0.0101	CbGeAlD
Vitamin E—GSTM3—smooth muscle tissue—urinary bladder cancer	0.000703	0.00991	CbGeAlD
Vitamin E—HMOX1—female reproductive system—urinary bladder cancer	0.000702	0.00989	CbGeAlD
Vitamin E—SEC14L2—lymph node—urinary bladder cancer	0.000682	0.00961	CbGeAlD
Vitamin E—PRKCB—lymph node—urinary bladder cancer	0.000682	0.00961	CbGeAlD
Vitamin E—GSTM3—renal system—urinary bladder cancer	0.000677	0.00954	CbGeAlD
Vitamin E—GSTM3—urethra—urinary bladder cancer	0.000665	0.00937	CbGeAlD
Vitamin E—GSTO1—smooth muscle tissue—urinary bladder cancer	0.000655	0.00923	CbGeAlD
Vitamin E—HMOX1—vagina—urinary bladder cancer	0.000635	0.00895	CbGeAlD
Vitamin E—GSTO1—renal system—urinary bladder cancer	0.00063	0.00888	CbGeAlD
Vitamin E—GSTO1—urethra—urinary bladder cancer	0.000619	0.00872	CbGeAlD
Vitamin E—ALOX5—prostate gland—urinary bladder cancer	0.000616	0.00868	CbGeAlD
Vitamin E—GCLC—female reproductive system—urinary bladder cancer	0.000607	0.00856	CbGeAlD
Vitamin E—PRKCA—epithelium—urinary bladder cancer	0.000605	0.00853	CbGeAlD
Vitamin E—SOD1—smooth muscle tissue—urinary bladder cancer	0.000602	0.00848	CbGeAlD
Vitamin E—PRKCA—smooth muscle tissue—urinary bladder cancer	0.000583	0.00822	CbGeAlD
Vitamin E—GSTA2—epithelium—urinary bladder cancer	0.00058	0.00817	CbGeAlD
Vitamin E—SOD1—urethra—urinary bladder cancer	0.000569	0.00802	CbGeAlD
Vitamin E—NQO1—prostate gland—urinary bladder cancer	0.000567	0.00799	CbGeAlD
Vitamin E—DGKA—lymph node—urinary bladder cancer	0.000564	0.00794	CbGeAlD
Vitamin E—PRKCA—renal system—urinary bladder cancer	0.000561	0.00791	CbGeAlD
Vitamin E—GCLC—vagina—urinary bladder cancer	0.000549	0.00774	CbGeAlD
Vitamin E—GSTM3—female reproductive system—urinary bladder cancer	0.000542	0.00764	CbGeAlD
Vitamin E—GSTA2—renal system—urinary bladder cancer	0.000538	0.00758	CbGeAlD
Vitamin E—GSTP1—prostate gland—urinary bladder cancer	0.000507	0.00714	CbGeAlD
Vitamin E—GSTO1—female reproductive system—urinary bladder cancer	0.000505	0.00711	CbGeAlD
Vitamin E—GSTM3—vagina—urinary bladder cancer	0.00049	0.00691	CbGeAlD
Vitamin E—NQO1—seminal vesicle—urinary bladder cancer	0.000479	0.00676	CbGeAlD
Vitamin E—PPP2CB—lymph node—urinary bladder cancer	0.000473	0.00666	CbGeAlD
Vitamin E—HMOX1—Doxorubicin—Valrubicin—urinary bladder cancer	0.000461	0.15	CbGdCrCtD
Vitamin E—HMOX1—Daunorubicin—Valrubicin—urinary bladder cancer	0.000461	0.15	CbGdCrCtD
Vitamin E—HMOX1—Epirubicin—Valrubicin—urinary bladder cancer	0.000461	0.15	CbGdCrCtD
Vitamin E—HMOX1—Idarubicin—Valrubicin—urinary bladder cancer	0.000461	0.15	CbGdCrCtD
Vitamin E—GSTO1—vagina—urinary bladder cancer	0.000456	0.00643	CbGeAlD
Vitamin E—PRKCA—female reproductive system—urinary bladder cancer	0.000449	0.00633	CbGeAlD
Vitamin E—ALOX5—smooth muscle tissue—urinary bladder cancer	0.000436	0.00615	CbGeAlD
Vitamin E—GSTA2—female reproductive system—urinary bladder cancer	0.000431	0.00607	CbGeAlD
Vitamin E—GSTP1—seminal vesicle—urinary bladder cancer	0.000428	0.00604	CbGeAlD
Vitamin E—SOD1—vagina—urinary bladder cancer	0.00042	0.00592	CbGeAlD
Vitamin E—NQO1—epithelium—urinary bladder cancer	0.000417	0.00587	CbGeAlD
Vitamin E—ALOX5—urethra—urinary bladder cancer	0.000412	0.00581	CbGeAlD
Vitamin E—HMOX1—lymph node—urinary bladder cancer	0.000411	0.00579	CbGeAlD
Vitamin E—NQO1—smooth muscle tissue—urinary bladder cancer	0.000401	0.00566	CbGeAlD
Vitamin E—NQO1—renal system—urinary bladder cancer	0.000386	0.00544	CbGeAlD
Vitamin E—NQO1—urethra—urinary bladder cancer	0.000379	0.00535	CbGeAlD
Vitamin E—GSTP1—epithelium—urinary bladder cancer	0.000372	0.00525	CbGeAlD
Vitamin E—GSTP1—smooth muscle tissue—urinary bladder cancer	0.000359	0.00505	CbGeAlD
Vitamin E—GCLC—lymph node—urinary bladder cancer	0.000355	0.005	CbGeAlD
Vitamin E—GSTP1—renal system—urinary bladder cancer	0.000345	0.00487	CbGeAlD
Vitamin E—GSTP1—urethra—urinary bladder cancer	0.000339	0.00478	CbGeAlD
Vitamin E—ALOX5—female reproductive system—urinary bladder cancer	0.000336	0.00474	CbGeAlD
Vitamin E—GSTM3—lymph node—urinary bladder cancer	0.000317	0.00447	CbGeAlD
Vitamin E—NQO1—female reproductive system—urinary bladder cancer	0.000309	0.00436	CbGeAlD
Vitamin E—HMOX1—Podofilox—Etoposide—urinary bladder cancer	0.000308	0.1	CbGdCrCtD
Vitamin E—GSTO1—lymph node—urinary bladder cancer	0.000295	0.00416	CbGeAlD
Vitamin E—NQO1—vagina—urinary bladder cancer	0.00028	0.00394	CbGeAlD
Vitamin E—GSTP1—female reproductive system—urinary bladder cancer	0.000276	0.0039	CbGeAlD
Vitamin E—SOD1—lymph node—urinary bladder cancer	0.000271	0.00383	CbGeAlD
Vitamin E—PRKCA—lymph node—urinary bladder cancer	0.000263	0.00371	CbGeAlD
Vitamin E—GSTP1—vagina—urinary bladder cancer	0.00025	0.00352	CbGeAlD
Vitamin E—ALOX5—lymph node—urinary bladder cancer	0.000197	0.00277	CbGeAlD
Vitamin E—NQO1—lymph node—urinary bladder cancer	0.000181	0.00255	CbGeAlD
Vitamin E—GSTP1—lymph node—urinary bladder cancer	0.000162	0.00228	CbGeAlD
Vitamin E—HMOX1—Daunorubicin—Epirubicin—urinary bladder cancer	0.00016	0.0521	CbGdCrCtD
Vitamin E—HMOX1—Idarubicin—Epirubicin—urinary bladder cancer	0.00016	0.0521	CbGdCrCtD
Vitamin E—HMOX1—Doxorubicin—Epirubicin—urinary bladder cancer	0.00016	0.0521	CbGdCrCtD
Vitamin E—HMOX1—Epirubicin—Doxorubicin—urinary bladder cancer	0.000148	0.0482	CbGdCrCtD
Vitamin E—HMOX1—Idarubicin—Doxorubicin—urinary bladder cancer	0.000148	0.0482	CbGdCrCtD
Vitamin E—HMOX1—Daunorubicin—Doxorubicin—urinary bladder cancer	0.000148	0.0482	CbGdCrCtD
Vitamin E—PRKCA—Metabolism—NQO1—urinary bladder cancer	5.04e-06	4.13e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Metabolism—CREBBP—urinary bladder cancer	5.04e-06	4.12e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—ERBB2—urinary bladder cancer	5.04e-06	4.12e-05	CbGpPWpGaD
Vitamin E—GCLC—Metabolism—EP300—urinary bladder cancer	5.03e-06	4.12e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Adaptive Immune System—HRAS—urinary bladder cancer	5.01e-06	4.1e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—ESR1—urinary bladder cancer	5e-06	4.09e-05	CbGpPWpGaD
Vitamin E—PRKCA—Hemostasis—IL2—urinary bladder cancer	4.98e-06	4.07e-05	CbGpPWpGaD
Vitamin E—PRKCA—Gene Expression—NCOR1—urinary bladder cancer	4.97e-06	4.07e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—RBX1—urinary bladder cancer	4.96e-06	4.06e-05	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	4.96e-06	4.06e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—FGFR3—urinary bladder cancer	4.95e-06	4.05e-05	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—ERBB2—urinary bladder cancer	4.95e-06	4.05e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—IL2—urinary bladder cancer	4.95e-06	4.05e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—PTGS2—urinary bladder cancer	4.93e-06	4.03e-05	CbGpPWpGaD
Vitamin E—PRKCA—Neuronal System—HRAS—urinary bladder cancer	4.93e-06	4.03e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—PPARG—urinary bladder cancer	4.91e-06	4.02e-05	CbGpPWpGaD
Vitamin E—GSTO1—Disease—HRAS—urinary bladder cancer	4.91e-06	4.02e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Innate Immune System—HRAS—urinary bladder cancer	4.88e-06	3.99e-05	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—CDKN1A—urinary bladder cancer	4.86e-06	3.97e-05	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—PTEN—urinary bladder cancer	4.84e-06	3.96e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by NGF—HRAS—urinary bladder cancer	4.83e-06	3.95e-05	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—PPARG—urinary bladder cancer	4.82e-06	3.95e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—ESR1—urinary bladder cancer	4.81e-06	3.93e-05	CbGpPWpGaD
Vitamin E—DGKA—Signaling Pathways—TP53—urinary bladder cancer	4.74e-06	3.88e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—CREBBP—urinary bladder cancer	4.72e-06	3.86e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—ERBB2—urinary bladder cancer	4.72e-06	3.86e-05	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle, Mitotic—EP300—urinary bladder cancer	4.72e-06	3.86e-05	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—PPARG—urinary bladder cancer	4.7e-06	3.84e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Adaptive Immune System—HRAS—urinary bladder cancer	4.69e-06	3.84e-05	CbGpPWpGaD
Vitamin E—PRKCA—Gene Expression—ERCC2—urinary bladder cancer	4.67e-06	3.82e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—CDKN1A—urinary bladder cancer	4.66e-06	3.81e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—TSC1—urinary bladder cancer	4.66e-06	3.81e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—PTEN—urinary bladder cancer	4.65e-06	3.81e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—FGFR3—urinary bladder cancer	4.63e-06	3.79e-05	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—CREBBP—urinary bladder cancer	4.63e-06	3.79e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—IL2—urinary bladder cancer	4.63e-06	3.79e-05	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—EP300—urinary bladder cancer	4.62e-06	3.78e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—NCOR1—urinary bladder cancer	4.62e-06	3.78e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—PTGS2—urinary bladder cancer	4.61e-06	3.77e-05	CbGpPWpGaD
Vitamin E—GSTA2—Metabolism—PTGS2—urinary bladder cancer	4.59e-06	3.75e-05	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle—CCND1—urinary bladder cancer	4.58e-06	3.75e-05	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—PPARG—urinary bladder cancer	4.55e-06	3.72e-05	CbGpPWpGaD
Vitamin E—DGKA—Signaling Pathways—HRAS—urinary bladder cancer	4.54e-06	3.71e-05	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—CREBBP—urinary bladder cancer	4.52e-06	3.69e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—ESR1—urinary bladder cancer	4.5e-06	3.68e-05	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—SRC—urinary bladder cancer	4.49e-06	3.67e-05	CbGpPWpGaD
Vitamin E—PRKCA—Hemostasis—EP300—urinary bladder cancer	4.47e-06	3.66e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—JAG1—urinary bladder cancer	4.44e-06	3.63e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—EP300—urinary bladder cancer	4.44e-06	3.63e-05	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle—CDKN1A—urinary bladder cancer	4.43e-06	3.63e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—CREBBP—urinary bladder cancer	4.39e-06	3.59e-05	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—CREBBP—urinary bladder cancer	4.37e-06	3.58e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—CDKN1A—urinary bladder cancer	4.37e-06	3.57e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—PTEN—urinary bladder cancer	4.36e-06	3.56e-05	CbGpPWpGaD
Vitamin E—PRKCA—Hemostasis—SRC—urinary bladder cancer	4.35e-06	3.56e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—ERCC2—urinary bladder cancer	4.34e-06	3.55e-05	CbGpPWpGaD
Vitamin E—NR1I2—Gene Expression—MYC—urinary bladder cancer	4.34e-06	3.55e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—IGF1—urinary bladder cancer	4.33e-06	3.54e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—SRC—urinary bladder cancer	4.32e-06	3.53e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling by GPCR—EGFR—urinary bladder cancer	4.31e-06	3.53e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—CDKN1A—urinary bladder cancer	4.31e-06	3.52e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—PTEN—urinary bladder cancer	4.3e-06	3.51e-05	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—CDKN1A—urinary bladder cancer	4.23e-06	3.46e-05	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—PTEN—urinary bladder cancer	4.22e-06	3.45e-05	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle—EP300—urinary bladder cancer	4.22e-06	3.45e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—CREBBP—urinary bladder cancer	4.21e-06	3.45e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—GSTP1—urinary bladder cancer	4.21e-06	3.44e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—IGF1—urinary bladder cancer	4.16e-06	3.4e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—EP300—urinary bladder cancer	4.16e-06	3.4e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling by GPCR—EGFR—urinary bladder cancer	4.14e-06	3.39e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Metabolism—PTGS2—urinary bladder cancer	4.13e-06	3.37e-05	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle, Mitotic—MYC—urinary bladder cancer	4.11e-06	3.36e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—EP300—urinary bladder cancer	4.1e-06	3.35e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—MTHFR—urinary bladder cancer	4.08e-06	3.34e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling by GPCR—KRAS—urinary bladder cancer	4.07e-06	3.33e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—TERT—urinary bladder cancer	4.07e-06	3.33e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—FGFR3—urinary bladder cancer	4.04e-06	3.31e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—SRC—urinary bladder cancer	4.04e-06	3.31e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—CDKN1A—urinary bladder cancer	4.03e-06	3.3e-05	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—EP300—urinary bladder cancer	4.02e-06	3.29e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—PTEN—urinary bladder cancer	4.02e-06	3.29e-05	CbGpPWpGaD
Vitamin E—GSTA2—Metabolism—PTEN—urinary bladder cancer	4e-06	3.27e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—SRC—urinary bladder cancer	3.98e-06	3.26e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—RHOA—urinary bladder cancer	3.97e-06	3.25e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—CREBBP—urinary bladder cancer	3.95e-06	3.23e-05	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—EGFR—urinary bladder cancer	3.94e-06	3.22e-05	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—SRC—urinary bladder cancer	3.91e-06	3.2e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling by GPCR—KRAS—urinary bladder cancer	3.91e-06	3.2e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—TYMS—urinary bladder cancer	3.91e-06	3.2e-05	CbGpPWpGaD
Vitamin E—PRKCA—Gene Expression—ESR1—urinary bladder cancer	3.9e-06	3.19e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—IGF1—urinary bladder cancer	3.9e-06	3.19e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling by GPCR—EGFR—urinary bladder cancer	3.88e-06	3.17e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—GSTM1—urinary bladder cancer	3.87e-06	3.16e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—NCOR1—urinary bladder cancer	3.87e-06	3.16e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—PTGS2—urinary bladder cancer	3.86e-06	3.16e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—EP300—urinary bladder cancer	3.84e-06	3.14e-05	CbGpPWpGaD
Vitamin E—GSTA2—Metabolism—EP300—urinary bladder cancer	3.82e-06	3.12e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—RHOA—urinary bladder cancer	3.81e-06	3.12e-05	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—PTGS2—urinary bladder cancer	3.79e-06	3.1e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—EGFR—urinary bladder cancer	3.78e-06	3.09e-05	CbGpPWpGaD
Vitamin E—PRKCA—GPCR downstream signaling—RHOA—urinary bladder cancer	3.75e-06	3.07e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—FGFR3—urinary bladder cancer	3.73e-06	3.05e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—SRC—urinary bladder cancer	3.73e-06	3.05e-05	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—KRAS—urinary bladder cancer	3.72e-06	3.04e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—GPX1—urinary bladder cancer	3.7e-06	3.03e-05	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—PTGS2—urinary bladder cancer	3.7e-06	3.02e-05	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle—MYC—urinary bladder cancer	3.68e-06	3.01e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—ERBB2—urinary bladder cancer	3.67e-06	3e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling by GPCR—KRAS—urinary bladder cancer	3.66e-06	3e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—ERCC2—urinary bladder cancer	3.63e-06	2.97e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Gene Expression—MYC—urinary bladder cancer	3.6e-06	2.95e-05	CbGpPWpGaD
Vitamin E—PRKCA—Hemostasis—KRAS—urinary bladder cancer	3.6e-06	2.94e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Metabolism—PTEN—urinary bladder cancer	3.6e-06	2.94e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—S100B—urinary bladder cancer	3.59e-06	2.94e-05	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—PTGS2—urinary bladder cancer	3.58e-06	2.93e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—KRAS—urinary bladder cancer	3.57e-06	2.92e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—MYC—urinary bladder cancer	3.57e-06	2.92e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—RHOA—urinary bladder cancer	3.57e-06	2.92e-05	CbGpPWpGaD
Vitamin E—PRKCA—Gene Expression—PPARG—urinary bladder cancer	3.56e-06	2.91e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—EGFR—urinary bladder cancer	3.54e-06	2.9e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—ERBB2—urinary bladder cancer	3.53e-06	2.89e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—EGFR—urinary bladder cancer	3.49e-06	2.86e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—CXCL8—urinary bladder cancer	3.48e-06	2.85e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling by GPCR—HRAS—urinary bladder cancer	3.46e-06	2.83e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—CREBBP—urinary bladder cancer	3.44e-06	2.82e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Metabolism—EP300—urinary bladder cancer	3.43e-06	2.81e-05	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—EGFR—urinary bladder cancer	3.43e-06	2.81e-05	CbGpPWpGaD
Vitamin E—PRKCA—Gene Expression—CREBBP—urinary bladder cancer	3.42e-06	2.8e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—CDH1—urinary bladder cancer	3.42e-06	2.79e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—MTHFR—urinary bladder cancer	3.42e-06	2.79e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by GPCR—RHOA—urinary bladder cancer	3.41e-06	2.79e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—PTEN—urinary bladder cancer	3.37e-06	2.76e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—KRAS—urinary bladder cancer	3.35e-06	2.74e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—CXCL8—urinary bladder cancer	3.35e-06	2.74e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—MYC—urinary bladder cancer	3.34e-06	2.74e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—IL2—urinary bladder cancer	3.33e-06	2.72e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling by GPCR—HRAS—urinary bladder cancer	3.32e-06	2.72e-05	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—PTEN—urinary bladder cancer	3.31e-06	2.71e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—ERBB2—urinary bladder cancer	3.3e-06	2.7e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—KRAS—urinary bladder cancer	3.3e-06	2.7e-05	CbGpPWpGaD
Vitamin E—PRKCA—GPCR downstream signaling—CXCL8—urinary bladder cancer	3.29e-06	2.69e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—EGFR—urinary bladder cancer	3.27e-06	2.68e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—CCND1—urinary bladder cancer	3.25e-06	2.65e-05	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—KRAS—urinary bladder cancer	3.24e-06	2.65e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—NCOR1—urinary bladder cancer	3.23e-06	2.64e-05	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—PTEN—urinary bladder cancer	3.22e-06	2.64e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Metabolism—EP300—urinary bladder cancer	3.21e-06	2.63e-05	CbGpPWpGaD
Vitamin E—PRKCA—Hemostasis—TP53—urinary bladder cancer	3.2e-06	2.62e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—IL2—urinary bladder cancer	3.2e-06	2.62e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—CREBBP—urinary bladder cancer	3.18e-06	2.6e-05	CbGpPWpGaD
Vitamin E—PRKCB—Immune System—HRAS—urinary bladder cancer	3.16e-06	2.59e-05	CbGpPWpGaD
Vitamin E—GSTP1—Metabolism—EP300—urinary bladder cancer	3.16e-06	2.58e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—MMP9—urinary bladder cancer	3.15e-06	2.58e-05	CbGpPWpGaD
Vitamin E—PRKCA—GPCR downstream signaling—IL2—urinary bladder cancer	3.15e-06	2.58e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—CDKN1A—urinary bladder cancer	3.14e-06	2.57e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—CXCL8—urinary bladder cancer	3.13e-06	2.56e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—PTEN—urinary bladder cancer	3.13e-06	2.56e-05	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—PTEN—urinary bladder cancer	3.12e-06	2.55e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—CCND1—urinary bladder cancer	3.12e-06	2.55e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling by GPCR—HRAS—urinary bladder cancer	3.11e-06	2.55e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—KRAS—urinary bladder cancer	3.09e-06	2.53e-05	CbGpPWpGaD
Vitamin E—NQO1—Metabolism—EP300—urinary bladder cancer	3.08e-06	2.52e-05	CbGpPWpGaD
Vitamin E—PRKCA—Hemostasis—HRAS—urinary bladder cancer	3.06e-06	2.5e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Immune System—HRAS—urinary bladder cancer	3.04e-06	2.48e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—MMP9—urinary bladder cancer	3.03e-06	2.48e-05	CbGpPWpGaD
Vitamin E—PRKCA—Cell Cycle—TP53—urinary bladder cancer	3.02e-06	2.47e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—CDKN1A—urinary bladder cancer	3.02e-06	2.47e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—PTEN—urinary bladder cancer	3.01e-06	2.46e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—IL2—urinary bladder cancer	2.99e-06	2.45e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by GPCR—CXCL8—urinary bladder cancer	2.99e-06	2.45e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—EP300—urinary bladder cancer	2.99e-06	2.44e-05	CbGpPWpGaD
Vitamin E—ALOX5—Metabolism—EP300—urinary bladder cancer	2.98e-06	2.44e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—CCND1—urinary bladder cancer	2.92e-06	2.39e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—SRC—urinary bladder cancer	2.9e-06	2.38e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—ERBB2—urinary bladder cancer	2.88e-06	2.36e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—RHOA—urinary bladder cancer	2.87e-06	2.35e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—EP300—urinary bladder cancer	2.87e-06	2.35e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by GPCR—IL2—urinary bladder cancer	2.86e-06	2.34e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—TERT—urinary bladder cancer	2.85e-06	2.33e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Immune System—HRAS—urinary bladder cancer	2.84e-06	2.33e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—MMP9—urinary bladder cancer	2.83e-06	2.32e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—CDKN1A—urinary bladder cancer	2.82e-06	2.31e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—PTEN—urinary bladder cancer	2.82e-06	2.3e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Disease—HRAS—urinary bladder cancer	2.8e-06	2.29e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—SRC—urinary bladder cancer	2.79e-06	2.28e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—PPARG—urinary bladder cancer	2.77e-06	2.27e-05	CbGpPWpGaD
Vitamin E—PRKCA—Innate Immune System—HRAS—urinary bladder cancer	2.75e-06	2.25e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—EP300—urinary bladder cancer	2.69e-06	2.2e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—CREBBP—urinary bladder cancer	2.66e-06	2.18e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—ERBB2—urinary bladder cancer	2.66e-06	2.18e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Disease—HRAS—urinary bladder cancer	2.63e-06	2.15e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—FGFR3—urinary bladder cancer	2.61e-06	2.14e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—SRC—urinary bladder cancer	2.61e-06	2.14e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—IL2—urinary bladder cancer	2.61e-06	2.14e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—MYC—urinary bladder cancer	2.6e-06	2.13e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—PTGS2—urinary bladder cancer	2.6e-06	2.13e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—EGFR—urinary bladder cancer	2.55e-06	2.08e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—ESR1—urinary bladder cancer	2.54e-06	2.08e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—MYC—urinary bladder cancer	2.5e-06	2.05e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—CDKN1A—urinary bladder cancer	2.46e-06	2.02e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—PTEN—urinary bladder cancer	2.46e-06	2.01e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—EGFR—urinary bladder cancer	2.45e-06	2e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—KRAS—urinary bladder cancer	2.41e-06	1.97e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—EP300—urinary bladder cancer	2.34e-06	1.92e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—MYC—urinary bladder cancer	2.34e-06	1.92e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—KRAS—urinary bladder cancer	2.31e-06	1.89e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—EGFR—urinary bladder cancer	2.29e-06	1.87e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—SRC—urinary bladder cancer	2.28e-06	1.86e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—CDKN1A—urinary bladder cancer	2.27e-06	1.86e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—PTEN—urinary bladder cancer	2.27e-06	1.86e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—CREBBP—urinary bladder cancer	2.23e-06	1.82e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—IGF1—urinary bladder cancer	2.2e-06	1.8e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by GPCR—EGFR—urinary bladder cancer	2.19e-06	1.79e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—PTGS2—urinary bladder cancer	2.18e-06	1.78e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—EP300—urinary bladder cancer	2.16e-06	1.77e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—KRAS—urinary bladder cancer	2.16e-06	1.77e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—TP53—urinary bladder cancer	2.14e-06	1.75e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—SRC—urinary bladder cancer	2.1e-06	1.72e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by GPCR—KRAS—urinary bladder cancer	2.07e-06	1.69e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—TP53—urinary bladder cancer	2.05e-06	1.68e-05	CbGpPWpGaD
Vitamin E—PRKCB—Signaling Pathways—HRAS—urinary bladder cancer	2.04e-06	1.67e-05	CbGpPWpGaD
Vitamin E—PRKCA—Gene Expression—MYC—urinary bladder cancer	2.03e-06	1.66e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—RHOA—urinary bladder cancer	2.01e-06	1.65e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—EGFR—urinary bladder cancer	2e-06	1.63e-05	CbGpPWpGaD
Vitamin E—PPP2CB—Signaling Pathways—HRAS—urinary bladder cancer	1.96e-06	1.61e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—TP53—urinary bladder cancer	1.92e-06	1.57e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—PTEN—urinary bladder cancer	1.9e-06	1.55e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—KRAS—urinary bladder cancer	1.89e-06	1.54e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—MYC—urinary bladder cancer	1.89e-06	1.54e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—ERBB2—urinary bladder cancer	1.86e-06	1.52e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—EGFR—urinary bladder cancer	1.84e-06	1.51e-05	CbGpPWpGaD
Vitamin E—PPP2CA—Signaling Pathways—HRAS—urinary bladder cancer	1.84e-06	1.5e-05	CbGpPWpGaD
Vitamin E—PRKCA—Metabolism—EP300—urinary bladder cancer	1.81e-06	1.48e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—CXCL8—urinary bladder cancer	1.77e-06	1.45e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling by GPCR—HRAS—urinary bladder cancer	1.76e-06	1.44e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—KRAS—urinary bladder cancer	1.74e-06	1.43e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—IL2—urinary bladder cancer	1.69e-06	1.38e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—CCND1—urinary bladder cancer	1.65e-06	1.35e-05	CbGpPWpGaD
Vitamin E—PRKCA—Immune System—HRAS—urinary bladder cancer	1.6e-06	1.31e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—MMP9—urinary bladder cancer	1.6e-06	1.31e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—CDKN1A—urinary bladder cancer	1.59e-06	1.3e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—PTEN—urinary bladder cancer	1.59e-06	1.3e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—EP300—urinary bladder cancer	1.52e-06	1.24e-05	CbGpPWpGaD
Vitamin E—PRKCA—Disease—HRAS—urinary bladder cancer	1.48e-06	1.21e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—SRC—urinary bladder cancer	1.47e-06	1.21e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—MYC—urinary bladder cancer	1.32e-06	1.08e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—EGFR—urinary bladder cancer	1.29e-06	1.06e-05	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—KRAS—urinary bladder cancer	1.22e-06	9.98e-06	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—TP53—urinary bladder cancer	1.08e-06	8.87e-06	CbGpPWpGaD
Vitamin E—PRKCA—Signaling Pathways—HRAS—urinary bladder cancer	1.04e-06	8.48e-06	CbGpPWpGaD
